Literature DB >> 629758

Isolation, composition and ordering of cyanogen bromide peptides in human casein.

M L Groves, R Greenberg.   

Abstract

The major component of the casein fraction of human milk was cleaved by cyanogen bromide, and the composition of the resulting peptides was determined. Casein was also subjected to limited digestion by trypsin, and the amino acid composition of the isolated peptides was established. With this information the peptides were ordered as they occur in the purified protein.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 629758      PMCID: PMC1184172          DOI: 10.1042/bj1690337

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  4 in total

1.  Abnormal human haemoglobins. I. The comparison of normal human and sickle-cell haemoglobins by fingerprinting.

Authors:  V M INGRAM
Journal:  Biochim Biophys Acta       Date:  1958-06

2.  Amino terminal sequence and location of phosphate groups of the major human casein.

Authors:  R Greenberg; M L Groves; R F Peterson
Journal:  J Dairy Sci       Date:  1976-06       Impact factor: 4.034

3.  On the structure of ovotransferrin. Isolation and characterization of the cyanogen bromide fragments and evidence for a duplicate structure.

Authors:  J L Phillips; P Azari
Journal:  Biochemistry       Date:  1971-03-30       Impact factor: 3.162

4.  The major component of human casein: a protein phosphorylated at different levels.

Authors:  M L Groves; W G Gordon
Journal:  Arch Biochem Biophys       Date:  1970-09       Impact factor: 4.013

  4 in total
  2 in total

1.  The construction, identification and characterisation of plasmids containing human alpha-lactalbumin cDNA sequences.

Authors:  L Hall; M S Davies; R K Craig
Journal:  Nucleic Acids Res       Date:  1981-01-10       Impact factor: 16.971

2.  Isolation and characterization of beta- and gamma-caseins from horse milk.

Authors:  S Visser; R Jenness; R J Mullin
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.